Bill Shakespeare—who in 2020 received one of the first Pfizer COVID jabs—has died.
81-year-old UK resident William “Bill” Shakespeare reportedly died last Thursday, doctors attributing the death to an “unrelated illness.”
Shakespeare was an inpatient at a frailty ward when he had his first jab in December of 2020, which he referred to as “wonderful.”
He died at the same hospital in Coventry where he received the shot, according to BirminghamLive.
Bill Shakespeare was only the second person in the world to get the Pfizer-BioNTech vaccine in December at University Hospital Coventry, soon after 91-year-old Margaret Keenan at the same hospital, according to The Telegraph.
Coventry councilor Jayne Innes worked closely with Bill and said he was a “keen photographer, loved jazz and socializing, and also loved the natural world and gardens,” according to The New York Post. Innes encouraged others to also “have the jab,” saying it would be the “best tribute to Bill.”
The modern-day William Shakespeare made headlines back on Dec. 8 when he received the American-made Pfizer-BioNTech shot at University Hospital Coventry, only 20 miles from the famous playwright’s birthplace of Stratford-Upon-Avon.
Also a grandfather, Shakespeare leaves behind his wife, Joy, and his sons, Julian and William.
The Daily Mail reports that Bill died “from a stroke.”
A local ABC station reported last month that Lincoln City Councilman Roy Christensen had also suffered what he described as a small stroke the same day he got his Pfizer shot.
Miami obstetrician Dr. Gregory Michael died on Jan. 4 of a hemorrhagic stroke, two weeks after getting the Pfizer vaccine, according to another report from The Post.
28-year-old healthcare worker Sara Stickles from the Swedish American Hospital, in Beloit, Wisconsin was recently admitted to the ICU just five days after receiving a second dose of Pfizer’s experimental mRNA vaccine. The previously healthy young woman was pronounced brain dead after cerebral angiography confirmed a severe hemorrhage stroke in her brain stem, according to Natural News.
Axios reports that the Trump administration had turned down Pfizer’s offer for an additional 100 million coronavirus vaccine doses last summer.
According to Business-Standard—an Indian English-language daily edition newspaper—India outright rejected Pfizer’s application for use of its vaccine, citing “serious adverse events.”
The South China Morning Post reported that Hong Kong had halted Pfizer vaccinations in March after finding “more than 50” defects.
“The Pfizer RNA based COVID-19 vaccine was approved by the US FDA under an emergency use authorization without long term safety data,” reads a January publication in the peer-reviewed Journal of Microbiology and Infectious Diseases. “The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefits,” reads another portion.
The publication indicates that Pfizer’s vaccine has long-term health effects not previously disclosed, including “ALS, front temporal lobar degeneration, Alzheimer’s disease, and other neurological degenerative diseases.”
The journal report ends, “The vaccine could be a bioweapon and even more dangerous than the original infection.”
Jon Fleetwood is Managing Editor for American Faith.
